Table 4 Diagnostic efficacy of subjective assessment, O-RADS (v1), O-RADS (v1) combined with SRR and O-RADS (v2022).

From: Validation of the diagnostic efficacy of O-RADS in adnexal masses

Assessment method

Sensitivity (%)

Specificity (%)

Accuracy (%)

PPV (%)

AUC

P

Subjective assessment

86.5

97.0

94.5

95.8

0.918

0.0255a

O-RADS (v1)

100

79.5

84.4

60.5

0.959

0.0133b

O-RADS (v1) and SRR

100

90.4

92.7

76.5

0.976

0.0009c

O-RADS (v2022)

100

86.1

89.4

70.3

0.970

0.1534d

  1. O-RADS, Ovarian-Adnexal Reporting and Data Systems; v, version; SRR, Simple Rules Risk assessment; PPV, Positive Predictive Value; Pa, subjective assessment compared with O-RADS (v2022); Pb, O-RADS (v1) compared with O-RADS (v2022); Pc, O-RADS (v1) compared with O-RADS (v1) combined SRR; Pd, O-RADS (v2022) compared with O-RADS (v1) combined SRR.